Assyro AI

Orange Book product · Generic (ANDA)

HYDROCODONE BITARTRATE

HYDROCODONE BITARTRATE

Generic (ANDA)ANDA 206986RX ALVOGEN

At a glance

Jan 21, 2020

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 21, 2020

    6 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

HYDROCODONE BITARTRATE

Strength

10MG

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

ANDA 206986

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of HYDROCODONE BITARTRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.